Boehringer Ingelheim has made significant strides in their research on progressive pulmonary fibrosis (PPF) with the successful results of their Phase III FIBRONEER™-ILD trial. This trial marks a critical milestone for Nerandomilast, an investigational oral preferential inhibitor of p
The biopharma industry is grappling with a persistent wave of layoffs as companies navigate financial constraints and strategic realignments. Despite hopes for a reprieve in 2024, the sector saw a 3% increase in layoffs compared to the previous year. This trend underscores the ongoing challenges
The pharmaceutical and medical technology sectors have long grappled with the complexities of clinical trial management. Traditionally, these processes involved disparate systems and manual workflows, leading to inefficiencies, data silos, and delays. However, the advent of electronic quality
The role of artificial intelligence (AI) in healthcare is expanding rapidly, and its application in prenatal care is proving to be a game-changer. Congenital heart defects (CHDs), the most common type of birth defect, often require early detection for timely intervention. Despite advancements in
California, often recognized as a trendsetter in healthcare policy, continues to forge its path with several new laws aimed at improving various aspects of the healthcare system. As the country anticipates shifts in federal healthcare policy under President-elect Donald Trump, California's
Amid growing discontent with the Turkish healthcare system, a coalition of health workers has taken decisive action to protest against new regulations they argue prioritize profit over patient care. Beginning with a five-day work stoppage on January 6, these protests culminated in a general
